World's Best Scientists 2026 revealed!
Eric W. Klee

Eric W. Klee

D-Index & Metrics

Molecular Biology

D-Index
55
Citations
10975
World Ranking
2274
National Ranking
1120

Eric W. Klee publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Eric W. Klee sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 271 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Eric W. Klee D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Eric W. Klee sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 55 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Eric W. Klee is a researcher affiliated with the Mayo Clinic in the United States. Their work primarily spans the fields of biochemistry, genetics, and molecular biology, with notable contributions in medicine. Over their career, they have produced a significant body of research focused on genetics and molecular biology, contributing to subfields such as genetics, molecular biology, pulmonary and respiratory medicine, cancer research, and surgery.

The scientist has concentrated on topics including genomics and rare diseases, genetics and neurodevelopmental disorders, genomic variations and chromosomal abnormalities, cancer genomics and diagnostics, epigenetics and DNA methylation, chronic lymphocytic leukemia research, and RNA modifications and cancer.

Eric W. Klee's frequent publication venues include:

  • Genetics in Medicine Open
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Genetics in Medicine
  • The American Journal of Human Genetics
  • American Journal of Medical Genetics Part A

Co-authors who have regularly collaborated with Eric W. Klee include:

  • Filippo Pinto e Vairo
  • Erica L. Macke
  • Brendan C. Lanpher
  • Gavin R. Oliver
  • Rory J. Olson

Some recent papers reflecting their research focus are:

  • Genome-wide detection of tandem DNA repeats that are expanded in autism, 2020, Nature
  • Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development, 2020, Neuron
  • Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease, 2020, npj Genomic Medicine
  • Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome, 2021, Nature Genetics
  • One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation, 2021, Genetics in Medicine

Best Publications

  • Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists.

    Somak Roy;Christopher Coldren;Arivarasan Karunamurthy;Nefize S. Kip

  • Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

    Mitesh J. Borad;Mia D. Champion;Jan B. Egan;Winnie S. Liang

  • Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.

    Suzette J. Bielinski;Janet E. Olson;Jyotishman Pathak;Richard M. Weinshilboum

  • AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

    Vincenzo Salpietro;Vincenzo Salpietro;Vincenzo Salpietro;Christine L Dixon;Hui Guo;Hui Guo;Oscar D Bello

  • Genome-wide detection of tandem DNA repeats that are expanded in autism.

    Brett Trost;Worrawat Engchuan;Charlotte M. Nguyen;Charlotte M. Nguyen;Bhooma Thiruvahindrapuram

  • Maple syrup urine disease: mechanisms and management

    Patrick R Blackburn;Jennifer M Gass;Filippo Pinto e Vairo;Kristen M Farnham

  • Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes

    Gwen Lomberk;Yuna Blum;Rémy Nicolle;Asha Nair

  • Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.

    Yuan Ji;Jennifer M. Skierka;Joseph H. Blommel;Brenda E. Moore

  • 3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer

    Yan W. Asmann;Eric W. Klee;E. Aubrey Thompson;Edith A. Perez

  • Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development

    Ashley L. Lennox;Mariah L. Hoye;Ruiji Jiang;Bethany L. Johnson-Kerner

  • Sentieon DNASeq Variant Calling Workflow Demonstrates Strong Computational Performance and Accuracy.

    Katherine Irene Kendig;Saurabh Baheti;Matthew A Bockol;Travis M Drucker

  • Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice

    Gaurav Aggarwal;Vijaya Ramachandran;Naureen Javeed;Thiruvengadam Arumugam

  • Bioinformatics for Clinical Next Generation Sequencing

    Gavin R. Oliver;Steven N. Hart;Eric W. Klee

  • Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma

    Rachael A Vaubel;Shulan Tian;Dioval Remonde;Mark A. Schroeder

  • Clinical spectrum and genotype–phenotype associations of KCNA2-related encephalopathies

    Silvia Masnada;Ulrike B S Hedrich;Elena Gardella;Julian Schubert

  • Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans.

    Hsiang Chih Lu;Hsiang Chih Lu;Qiumin Tan;Maxime W.C. Rousseaux;Wei Wang

  • Global methylation profiling for risk prediction of prostate cancer

    Saswati Mahapatra;Eric W. Klee;Charles Y.F. Young;Zhifu Sun

  • LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer

    Olga P. Bondar;David R. Barnidge;Eric W. Klee;Brian J. Davis

  • Zebrafish: a model for the study of addiction genetics

    Eric W. Klee;Henning Schneider;Karl J. Clark;Margot A. Cousin

  • Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing

    Linnea M. Baudhuin;Susan A. Lagerstedt;Eric W. Klee;Numrah Fadra

Frequent Co-Authors

Raul Urrutia
Raul Urrutia Medical College of Wisconsin
Eric D. Wieben
Eric D. Wieben Mayo Clinic
George G. Klee
George G. Klee Mayo Clinic
Stephen C. Ekker
Stephen C. Ekker Mayo Clinic
George Vasmatzis
George Vasmatzis Mayo Clinic
Yan W. Asmann
Yan W. Asmann Mayo Clinic
Eva Morava
Eva Morava Mayo Clinic
Ingo Helbig
Ingo Helbig Children's Hospital of Philadelphia
Evan E. Eichler
Evan E. Eichler University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Molecular Biology can open doors to numerous allied health and science careers. For students interested in connecting biology with healthcare, there are accredited paths such as asha accredited online slp programs, which prepare graduates to become Speech-Language Pathologists. These programs are flexible and meet professional standards, making them ideal for career changers or those seeking online options.

If you have a non-SLP background, considering slp bridge programs is a practical step. These online bridge programs help biology and science graduates transition efficiently into Speech-Language Pathology graduate studies.

Many Molecular Biology graduates are also drawn to nursing careers. For a rapid entry into the field, accelerated bsn programs for non nurses offer a streamlined curriculum for those with prior degrees, preparing students for licensure and advanced healthcare roles.

Lastly, advanced practice roles such as Psychiatric Nurse Practitioner are in high demand nationwide. For information about potential earnings, see dnp pmhnp salary to gain insight into compensation trends by state.

Best Scientists Citing Eric W. Klee

Trending Scientists

Recently Published Articles